A Ligand-targeted Calcium-phosphate Drug Delivery System for Cancer
Time: 2:45 pm
day: Conference Day Two
Details:
- Alternatives to traditional RNAi delivery approaches are needed for cancer targets
- ARIZ’s preclinical novel siRNA formulated in a calcium-phosphate drug delivery system with a tumor targeting ligand, targets a histone methyltransferase that is one of the earliest changes in cancerization of the cell
- Proof of concept with our ligand targeted calcium-phosphate siRNA-conjugate delivery platform broadly solves delivery issues beyond liver cells with specificity for cancer cells.
